Research institute
Mymetics Corporation announced today that Mymetics BV, the Dutch subsidiary of Mymetics Corporation, has entered into a research collaboration project with eTheRNA immunotherapies NV, a clinical stage biotech company developing novel mRNA cancer immunotherapies.
The Society for Clinical Research Sites (SCRS) announced to almost 1,000 attendees at their 2018 Global Site Solutions Summit that AstraZeneca is the winning sponsor, and Syneos Health (formerly INC Research/inVentiv Health) is the winning CRO of the 2018 SCRS Eagle Award.
Hemogenyx Pharmaceuticals Plc announces that its wholly owned subsidiary, Immugenyx, LLC (“Immugenyx”), has entered into a collaboration agreement with Janssen Research & Development, LLC (“Janssen”), one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The agreement was facilitated by Johnson & Johnson Innovation LLC.
Another scientific paper has been retracted by the New England Journal of Medicine. The noted journal said it retracted a paper on evidence of human lung stem cells following an investigation that revealed images used in the article had been manipulated.
Again and again … and again, drugs have failed in clinical trials for Alzheimer’s disease. According to a new report, in the last decade, 146 drugs have failed in clinical trials for Alzheimer’s.
Researchers at Main Line Health’s Lankenau Institute for Medical Research (LIMR) have isolated an antibody that may offer a new strategy to treat ulcerative colitis (UC).
Local CRO Funds all STEM projects at high-poverty schools,
Researchers at Johns Hopkins, the University of California, San Diego, and the National Institute of Mental Health grew retinas in petri dishes, and discovered fundamental factors involved in the development of vision and color vision.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
PRESS RELEASES